#China Biotech
Total 2 articles
PoliticsEN
BlackRock Investment in Chinese Biotech 2026: Global Funds Double Down
Global institutional investors, including BlackRock and Temasek, are securing major stakes in China's top biotech firms in 2026. Explore the strategic motivations.
·
HK
Haneul KimPoliticsEN
Renowned Immunologist Andrew Macpherson Joins China's USTC as Brain Drain Reverses
European immunologist Andrew Macpherson has joined China's USTC full-time. Explore how this move signals China's rise as a global hub for biomedical research.
·
HK
Haneul Kim